Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways

Docetaxel is the first-line chemotherapy agent for metastatic prostate cancer. However, the emergence of resistance diminishes its efficacy and limits the survival benefit. Quercetin is a dietary flavonoid which has been shown to have multiple anti-cancer effects. Also, quercetin has been reported t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xinxing, Yang, Feiya, Chen, Dexi, Zhao, Qinxin, Chen, Dong, Ping, Hao, Xing, Nianzeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053318/
https://www.ncbi.nlm.nih.gov/pubmed/32174789
http://dx.doi.org/10.7150/ijbs.41686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053318/
https://www.ncbi.nlm.nih.gov/pubmed/32174789
http://dx.doi.org/10.7150/ijbs.41686

Ejemplares similares